Evolent Health, Inc with ticker code (EVH) now have 6 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 37 and 20 calculating the mean target price we have 30. Now with the previous closing price of 30.42 this indicates there is a potential downside of -1.4%. The 50 day moving average now sits at 28.22 and the 200 day MA is 22.89. The market capitalisation for the company is $2,612m. Visit the company website at: http://www.evolenthealth.com
Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health was founded in 2011 and is headquartered in Arlington, Virginia.
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.